Linezolide Viatris (Linezolid)

Linezolid is indicated for several bacterial infections where Gram‑positive organisms are the primary pathogens.

• Skin and soft tissue infections: effective treatment of infections caused by susceptible Gram‑positive bacteria.
• Community‑acquired pneumonia: eradicates susceptible organisms responsible for lower respiratory tract infection.
• Nosocomial pneumonia: provides coverage against hospital‑acquired Gram‑positive pathogens.
• Methicillin‑resistant Staphylococcus aureus (MRSA) infections: active against resistant strains in various sites.
• Vancomycin‑resistant Enterococcus (VRE) infections: offers an alternative oral option for resistant enterococcal disease.

• Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit. This binding prevents the formation of the initiation complex, halting translation and ultimately leading to bacteriostatic activity against susceptible Gram‑positive organisms.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: transient gastrointestinal upset.
• Diarrhea: loose stools, often self‑limiting.
• Headache: mild to moderate intensity.
• Metallic taste: temporary alteration of taste perception.
• Vomiting: occasional emesis.
• Insomnia: difficulty sleeping reported in some patients.

Serious or Rare Side Effects

• Thrombocytopenia: significant drop in platelet count requiring monitoring.
• Peripheral neuropathy: nerve damage presenting as tingling or numbness.
• Serotonin syndrome: risk when combined with serotonergic agents.
• Lactic acidosis: rare metabolic disturbance.
• Optic neuropathy: vision changes that may be irreversible.
• Myelosuppression: bone‑marrow suppression affecting blood cell production.

Before prescribing Linezolide Viatris, clinicians should consider several safety aspects.

• Renal impairment: monitor renal function and adjust therapy as needed.
• Hepatic disease: use with caution in patients with liver dysfunction.
• Hematologic disorders: observe complete blood counts for thrombocytopenia or anemia.
• Serotonergic medication use: avoid concurrent use due to risk of serotonin syndrome.
• Pregnancy and lactation: assess risk‑benefit ratio; limited data available.
• Store at room temperature: keep in original packaging, protect from moisture and light.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

• Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: risk of serotonin syndrome.
• Monoamine oxidase inhibitors (MAOIs): may cause hypertensive crisis.
• Meperidine and other opioids with serotonergic activity: increased serotonin toxicity.

Moderate Interactions (Monitor Closely)

• Warfarin: enhanced anticoagulant effect, monitor INR.
• Rifampin: induces metabolism, reducing linezolid plasma levels.
• Antacids containing magnesium or aluminum: may affect absorption, separate dosing times.
• Ethanol: potential for disulfiram‑like reaction, advise moderation.